# Single Injection Adductor Canal Block vs Catheter for Total Knee Arthroplasty

> **NCT02798835** · PHASE4 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 180 (actual)

## Conditions studied

- Total Knee Arthroplasty

## Interventions

- **DRUG:** Adductor canal block
- **DRUG:** Adductor canal block with dexamethasone
- **DRUG:** Adductor canal catheter
- **DRUG:** Bupivacaine
- **DRUG:** Fentanyl
- **DRUG:** Ropivacaine 0.5% Injectable Solution
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02798835
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2020-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02798835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02798835, "Single Injection Adductor Canal Block vs Catheter for Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT02798835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*